Washington — The Trump administration is standing firm on its recent reforms to the National Institutes of Health (NIH) grant review process, asserting that the changes are essential to ensure that federal research dollars support solid, evidence‑based science rather than political agendas.
Administration’s Rationale
President Trump and Health Secretary Robert F. Kennedy Jr. have repeatedly emphasized that the federal government must fund research that delivers tangible health benefits and economic growth. In a recent statement, the administration said the new screening measures are designed to eliminate funding for projects that prioritize diversity, equity and inclusion (DEI) initiatives over rigorous scientific methodology.
“We cannot allow taxpayer money to be used to advance partisan viewpoints,” the administration explained. “Our goal is to return NIH to its core mission of advancing medical breakthroughs that save lives and create jobs for American families.”
Scientists’ Lawsuit
A coalition of researchers filed a class‑action lawsuit in the U.S. District Court for the Northern District of California, alleging that the NIH is unconstitutionally screening grant applications for terms such as “gender,” “Latinx” and “climate change.” The plaintiffs claim the agency uses a list of 235 keywords to flag grants for termination, denial, or forced renegotiation, effectively imposing an ideological litmus test after peer review.
Arghavan Salles, a surgeon and clinical associate professor at Stanford University, said her grant on sexual harassment in biomedical research was terminated as “DEI‑related.” She argued that scientists should not have to “scrub their research to receive federal funding.”
Legal Background
The lawsuit follows a June 2025 federal court decision that declared NIH’s DEI‑related grant terminations unlawful. However, in August 2025 the Supreme Court allowed the agency to continue cutting $783 million in such grants. A federal appeals court in May 2026 ruled that the terminations likely violated the First Amendment, prompting the administration to request Supreme Court review of that decision.
The plaintiffs seek a court order to vacate the NIH’s screening policies and to restore the terminated grants. They allege violations of the First Amendment and statutory protections governing grant terminations.
Administration’s Response
In response, the Trump administration has reiterated that the NIH’s actions are consistent with congressional mandates that prohibit politicization of federal research funding. The administration argues that the screening process is a safeguard against the misuse of public funds for projects that do not meet rigorous scientific standards.
“Our policies reflect the will of Congress and the American people,” said a spokesperson for the White House. “We will continue to defend the integrity of the nation’s most important biomedical research agency.”
Implications for Researchers
If the lawsuit succeeds, NIH could be required to abandon its keyword‑based screening, potentially reopening funding for projects that the administration currently deems ideologically driven. Critics of the administration’s approach warn that without such oversight, federal funds could be diverted to studies that lack clear scientific merit.
Supporters, however, argue that the reforms protect taxpayers from funding initiatives that prioritize political narratives over measurable health outcomes. They contend that the administration’s focus on “solid science” aligns with the values of traditional families and the broader community.
What’s Next?
The case is set to move forward in the federal courts, with both sides preparing extensive legal arguments. The outcome could shape how federal research agencies balance scientific freedom with accountability to the American public.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
